U.S. launch expected in early February – – Niktimvo is the first and only approved treatment for chronic GVHD that targets CSF-1R to reduce the drive ...
25 Years of the 21st Century 25 Years of the 21st Century: 1. The Age of Digital Warfare Matthew and his guests look back at some of the big events of the past 25 years.
SurGenTec earned FDA 510(k) clearance for its OsteoFlo HydroFiber to be used as a stand-alone equivalent to autografts in spine surgeries.
Dean has Radio 1's Early Breakfast.
APL Apollo Tubes Ltd., incorporated in the year 1986, is a Mid Cap company (having a market cap of Rs 39,522.27 Crore) operating in Metals - Ferrous sector. APL Apollo Tubes Ltd. key Products/Revenue ...